If you are currently using other weight management medications or supplements alongside GLP-1 drugs , discuss adding Activate with your provider to avoid potential interactions
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials [published correction appears in Lancet Diabetes Endocrinol
Unlike oral supplements, IV therapy bypasses digestion, allowing for higher absorption and more noticeable results
But insulin also regulates fat and protein metabolism
Combining multiple resistance markers with genetic data and traditional drug efficacy tests can provide a comprehensive picture of resistance patterns
The exciting beyond obesity frontier for GLP-1 drugs is their potential to treat conditions where inflammation, or other non-obesity factors, are the primary cause